Published in Blood Press on December 20, 2013
Nighttime Valsartan in Hemodialysis Hypertension (NVHH) | NCT03594825
Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) | NCT03692013
Whole Exome Sequencing in CKD Hypertension (WESCH) | NCT03718585
Redo renal denervation using a multi-electrode radiofrequency system in patients with persistent therapy-resistant hypertension. Neth Heart J (2017) 0.86
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress. Antioxid Redox Signal (2015) 0.86
Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. J Hum Hypertens (2015) 0.83
Prevalence and predictors of resistance and aerobic exercise among hypertensive adults in the United States. J Hum Hypertens (2014) 0.83
Validation and Assessment of Three Methods to Estimate 24-h Urinary Sodium Excretion from Spot Urine Samples in Chinese Adults. PLoS One (2016) 0.82
Personalized approach to primary and secondary prevention of ischemic stroke. EPMA J (2014) 0.80
Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009. BMC Public Health (2015) 0.80
Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. J Hum Hypertens (2016) 0.79
Comprehensive approach to diabetic nephropathy. Kidney Res Clin Pract (2014) 0.79
Exercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging Research. Curr Hypertens Rep (2015) 0.79
Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore) (2015) 0.78
Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis. Clin Interv Aging (2016) 0.78
Resistant hypertension: do all definitions describe the same patients? J Hum Hypertens (2015) 0.77
Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study. Patient Prefer Adherence (2014) 0.77
Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study). J Am Heart Assoc (2016) 0.77
Pathophysiological effects of different risk factors for heart failure. Open Heart (2016) 0.76
A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk. PLoS One (2015) 0.76
Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy. PLoS One (2015) 0.76
A numerical scale to assess the outcomes of metabolic/bariatric surgery (NOMS). Wideochir Inne Tech Maloinwazyjne (2015) 0.76
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill. Curr Hypertens Rep (2016) 0.76
Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integr Blood Press Control (2016) 0.76
Quality of life, depression and dietary intake in Obstructive Sleep Apnea patients. Health Qual Life Outcomes (2016) 0.76
A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B. Therap Adv Gastroenterol (2016) 0.75
Inspiratory Muscle Training Improves Sleep and Mitigates Cardiovascular Dysfunction in Obstructive Sleep Apnea. Sleep (2016) 0.75
The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysis. Ther Clin Risk Manag (2015) 0.75
Analysis of the genetic association between IL27 variants and coronary artery disease in a Chinese Han population. Sci Rep (2016) 0.75
Unusual circadian hypertension associated with polydipsia. J Geriatr Cardiol (2016) 0.75
Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertension. Exp Ther Med (2017) 0.75
Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study. Hypertens Res (2016) 0.75
Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial. Int J Hypertens (2015) 0.75
Arterial-ventricular coupling and parameters of vascular stiffness in hypertensive patients: Role of gender. JRSM Cardiovasc Dis (2017) 0.75
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study. Front Pharmacol (2016) 0.75
Impact of primary care nursing workforce characteristics on the control of high-blood pressure: a multilevel analysis. BMJ Open (2015) 0.75
Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. J Am Heart Assoc (2016) 0.75
Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study. Medicine (Baltimore) (2016) 0.75
Dietary and cardio-metabolic risk factors in patients with Obstructive Sleep Apnea: cross-sectional study. PeerJ (2017) 0.75
Blood pressure changes during 22-year of follow-up in large general population - the HUNT Study, Norway. BMC Cardiovasc Disord (2016) 0.75
Age and hypertension strongly induce aortic stiffening in rats at basal and matched blood pressure levels. Physiol Rep (2016) 0.75
The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients. Clinics (Sao Paulo) (2016) 0.75
Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME. Nat Rev Endocrinol (2017) 0.75
Association of Family History With Cardiovascular Disease in Hypertensive Individuals in a Multiethnic Population. J Am Heart Assoc (2016) 0.75
Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors. Medicine (Baltimore) (2015) 0.75
Hypertension in the elderly: new blood pressure targets and prescribing tips. Can Fam Physician (2014) 0.75
Hypertension management by practice guidelines. Blood Press (2014) 0.75
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
Effects of parental smoking on exercise systolic blood pressure in adolescents. J Am Heart Assoc (2015) 0.75
Resistance Training in Spontaneously Hypertensive Rats with Severe Hypertension. Arq Bras Cardiol (2016) 0.75
C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function. Croat Med J (2015) 0.75
Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost(®)) and a Gouda-type cheese on blood pressure: results of a randomised trial. Food Nutr Res (2016) 0.75
Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol. Heart Asia (2016) 0.75
Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II. J Cardiovasc Pharmacol (2015) 0.75
Impact of aortic root size on left ventricular afterload and stroke volume. Eur J Appl Physiol (2016) 0.75
Longitudinal patterns of Cardiorespiratory fitness predict the development of Hypertension among Men and Women. Am J Med (2016) 0.75
Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review. JMIR Res Protoc (2017) 0.75
Normal values of regional left ventricular myocardial thickness, mass and distribution-assessed by 320-detector computed tomography angiography in the Copenhagen General Population Study. Int J Cardiovasc Imaging (2016) 0.75
Baroreflex gain and vasomotor sympathetic modulation in resistant hypertension. Clin Auton Res (2017) 0.75
Carotid Intima-Media Thickness and Prediction of Cardiovascular Disease. J Am Heart Assoc (2017) 0.75
Sex, BMI and age differences in metabolic syndrome: The Dutch Lifelines Cohort Study. Endocr Connect (2017) 0.75
Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters. Endocrine (2017) 0.75
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med (2005) 12.03
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09